Efficacy of patient-controlled paravertebral block for single intercostal video assisted thoracic surgery

A randomized clinical trial to assess the efficacy of patient-controlled paravertebral block versus intravenous patients controlled analgesia for patients undergoing single intercostal video assisted thoracic surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN24097424

Enrollment

260

Registered

2016-11-18

Start date

2015-06-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain in the postoperative period Signs and Symptoms

Interventions

Patients are randomised into two groups: 1. In the PVB group, patients receive single intercostal video-assisted thoracic surgery and patient-controlled paravertebral block for postoperative analgesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with solitary pulmonary nodule and spontaneous pneumothorax 2. Suitable for single intercostal video assisted thoracic surgery 3. Aged 18 to 80

Exclusion criteria

Exclusion criteria: 1. Patients with unresectable tumors 2. Older than 80 years old

Design outcomes

Primary

Measure	Time frame
Pain after surgery, measured using visual analogue score (VAS) until day 3 after surgery	—

Secondary

Measure	Time frame
1. The number of patients who receive rescue medication, measured on postoperative days 0, 1, 2 and 3 2. Complications after surgery, such as nausea and vomiting, hypertension, chylothorax and atrial fibrillation, measured after surgery and before discharge 3. The number of patients who are capable of a good cough, measured on postoperative days 0, 1, 2 and 3 4. Total hospital stay, measured on discharge 5. Time in the ICU, measured on discharge 6. Mortality within 30 days	—

Measure

Time frame

1. The number of patients who receive rescue medication, measured on postoperative days 0, 1, 2 and 3 2. Complications after surgery, such as nausea and vomiting, hypertension, chylothorax and atrial fibrillation, measured after surgery and before discharge 3. The number of patients who are capable of a good cough, measured on postoperative days 0, 1, 2 and 3 4. Total hospital stay, measured on discharge 5. Time in the ICU, measured on discharge 6. Mortality within 30 days

—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026